Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Do not push through severe side effects in silence
Vitiligo Repigmentation (Phase II Data) Afamelanotide has been studied as a combination therapy with narrowband UV-B (NB-UVB) phototherapy for nonsegmental vitiligo
It helps regulate appetite, slows gastric emptying, supports glucose-dependent insulin release, and reduces inappropriate glucagon secretion
Lower Risk Across All Key Outcomes with GLP-1RA Compared with DPP-4 inhibitors, GLP-1RA use was associated with significantly lower risks of MACE (hazard ratio [HR]: 0.66), VTE (HR: 0.49), kidney disease progression (HR: 0.77), and all-cause mortality (HR: 0.26)
US$ 26.48
US$ 25.65
US$ 20.42
US$ 28.10
